Filtros : "Lancet" "Inglaterra" Removido: "TABAGISMO" Limpar

Filtros



Refine with date range


  • Source: Lancet. Unidade: FM

    Subjects: MORTALIDADE, QUALIDADE DE VIDA, ATENÇÃO À SAÚDE, ÍNDICES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BARBER, Ryan M e BENSEÑOR, Isabela Judith Martins e LOTUFO, Paulo Andrade. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015:: a novel analysis from the Global Burden of Disease Study 2015. Lancet, v. 390, n. 10113, p. 2627-2642, 2017Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(17)30818-8. Acesso em: 08 nov. 2024.
    • APA

      Barber, R. M., Benseñor, I. J. M., & Lotufo, P. A. (2017). Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015:: a novel analysis from the Global Burden of Disease Study 2015. Lancet, 390( 10113), 2627-2642. doi:10.1016/S0140-6736(17)30818-8
    • NLM

      Barber RM, Benseñor IJM, Lotufo PA. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015:: a novel analysis from the Global Burden of Disease Study 2015 [Internet]. Lancet. 2017 ; 390( 10113): 2627-2642.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/S0140-6736(17)30818-8
    • Vancouver

      Barber RM, Benseñor IJM, Lotufo PA. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015:: a novel analysis from the Global Burden of Disease Study 2015 [Internet]. Lancet. 2017 ; 390( 10113): 2627-2642.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/S0140-6736(17)30818-8
  • Source: Lancet. Unidade: FM

    Subjects: PAPILOMA BUCAL, PAPILLOMAVIRUS, ESTUDOS DE COORTES, HOMENS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      KREIMER, Aimée R. et al. Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study. Lancet, v. 382, n. 9895, p. 877-887, 2013Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(13)60809-0. Acesso em: 08 nov. 2024.
    • APA

      Kreimer, A. R., Campbell, C. M. P., Lin, H. -Y., Fulp, W., Papenfuss, M. R., Abrahamsen, M., et al. (2013). Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study. Lancet, 382( 9895), 877-887. doi:10.1016/S0140-6736(13)60809-0
    • NLM

      Kreimer AR, Campbell CMP, Lin H-Y, Fulp W, Papenfuss MR, Abrahamsen M, Hildesheim A, Villa LL, Salmerón JJ, Lazcano-Ponce E, Giuliano AR. Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study [Internet]. Lancet. 2013 ; 382( 9895): 877-887.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/S0140-6736(13)60809-0
    • Vancouver

      Kreimer AR, Campbell CMP, Lin H-Y, Fulp W, Papenfuss MR, Abrahamsen M, Hildesheim A, Villa LL, Salmerón JJ, Lazcano-Ponce E, Giuliano AR. Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study [Internet]. Lancet. 2013 ; 382( 9895): 877-887.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/S0140-6736(13)60809-0
  • Source: Lancet. Unidade: FM

    Subjects: ANGINA INSTÁVEL, INFARTO DO MIOCÁRDIO, ANGIOGRAFIA, CORONORAIOPATIA, DOENÇAS CARDIOVASCULARES (MORTALIDADE), REVASCULARIZAÇÃO MIOCÁRDICA (COMPLICAÇÕES)

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      WIVIOTT, Stephen D. et al. Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial. Lancet, v. 382, n. 9892, p. 605-613, 2013Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(13)61451-8. Acesso em: 08 nov. 2024.
    • APA

      Wiviott, S. D., White, H. D., Ohman, E. M., Fox, K. A. A., Armstrong, P. W., Prabhakaran, D., et al. (2013). Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial. Lancet, 382( 9892), 605-613. doi:10.1016/S0140-6736(13)61451-8
    • NLM

      Wiviott SD, White HD, Ohman EM, Fox KAA, Armstrong PW, Prabhakaran D, Hafley GYL, Lokhnygina Y, Boden WE, Hamm C, Clemmensen P, Nicolau JC, Menozzi A, Ruzyllo W, Widimsky P, Oto A, Leiva-Pons J, Pavlides G, Winters KJ, Roe MT, Bhatt DL. Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial [Internet]. Lancet. 2013 ; 382( 9892): 605-613.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/S0140-6736(13)61451-8
    • Vancouver

      Wiviott SD, White HD, Ohman EM, Fox KAA, Armstrong PW, Prabhakaran D, Hafley GYL, Lokhnygina Y, Boden WE, Hamm C, Clemmensen P, Nicolau JC, Menozzi A, Ruzyllo W, Widimsky P, Oto A, Leiva-Pons J, Pavlides G, Winters KJ, Roe MT, Bhatt DL. Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial [Internet]. Lancet. 2013 ; 382( 9892): 605-613.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/S0140-6736(13)61451-8
  • Source: Lancet. Unidade: FM

    Subjects: FATORES DE RISCO, LIPÍDEOS, DOENÇAS CARDIOVASCULARES (GENÉTICA), HIPERCOLESTEROLEMIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SANTOS, Raul D. Lipid-lowering treatment for homozygous familial hypercholesterolaemia [Carta]. Lancet. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/S0140-6736(13)60797-7. Acesso em: 08 nov. 2024. , 2013
    • APA

      Santos, R. D. (2013). Lipid-lowering treatment for homozygous familial hypercholesterolaemia [Carta]. Lancet. London: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/S0140-6736(13)60797-7
    • NLM

      Santos RD. Lipid-lowering treatment for homozygous familial hypercholesterolaemia [Carta] [Internet]. Lancet. 2013 ; 381( 9873): 1182.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/S0140-6736(13)60797-7
    • Vancouver

      Santos RD. Lipid-lowering treatment for homozygous familial hypercholesterolaemia [Carta] [Internet]. Lancet. 2013 ; 381( 9873): 1182.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/S0140-6736(13)60797-7
  • Source: Lancet. Unidade: ICB

    Assunto: FARMACOLOGIA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CHOW, Roberta et al. Authors' reply [Carta]. Lancet. London: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 08 nov. 2024. , 2010
    • APA

      Chow, R., Johnson, M., Bjordal, J., & Martins, R. Á. B. L. (2010). Authors' reply [Carta]. Lancet. London: Instituto de Ciências Biomédicas, Universidade de São Paulo.
    • NLM

      Chow R, Johnson M, Bjordal J, Martins RÁBL. Authors' reply [Carta]. Lancet. 2010 ; 375( 9716): 722.[citado 2024 nov. 08 ]
    • Vancouver

      Chow R, Johnson M, Bjordal J, Martins RÁBL. Authors' reply [Carta]. Lancet. 2010 ; 375( 9716): 722.[citado 2024 nov. 08 ]
  • Source: Lancet. Unidade: FSP

    Subjects: SÍNDROME DE IMUNODEFICIÊNCIA ADQUIRIDA (PREVENÇÃO E CONTROLE;TRATAMENTO), SISTEMA ÚNICO DE SAÚDE (PRINCÍPIOS), POLÍTICA DE SAÚDE

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      KALICHMAN, Artur Olhovetchi e DINIZ, Carmen Simone Grilo. AIDS treatment in Brazil [Correspondence]: what kind of evidence do we need?. Lancet, v. 374, n. 9695, p. Se 2009, 2009Tradução . . Acesso em: 08 nov. 2024.
    • APA

      Kalichman, A. O., & Diniz, C. S. G. (2009). AIDS treatment in Brazil [Correspondence]: what kind of evidence do we need? Lancet, 374( 9695), Se 2009.
    • NLM

      Kalichman AO, Diniz CSG. AIDS treatment in Brazil [Correspondence]: what kind of evidence do we need? Lancet. 2009 ; 374( 9695): Se 2009.[citado 2024 nov. 08 ]
    • Vancouver

      Kalichman AO, Diniz CSG. AIDS treatment in Brazil [Correspondence]: what kind of evidence do we need? Lancet. 2009 ; 374( 9695): Se 2009.[citado 2024 nov. 08 ]
  • Source: Lancet. Unidade: ICB

    Assunto: FARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CHOW, Roberta T. et al. Efficacy of low-level laser therapy in the management of neck pain: a systematic review and meta-analysis of randomised placebo or active-treatment controlled trials. Lancet, v. 374, n. 9705, p. 1897-1908, 2009Tradução . . Disponível em: https://doi.org/10.1016/s0140-6736(09)61522-1. Acesso em: 08 nov. 2024.
    • APA

      Chow, R. T., Johnson, M. I., Lopes-Martins, R. Á. B., & Bjordal, J. M. (2009). Efficacy of low-level laser therapy in the management of neck pain: a systematic review and meta-analysis of randomised placebo or active-treatment controlled trials. Lancet, 374( 9705), 1897-1908. doi:10.1016/s0140-6736(09)61522-1
    • NLM

      Chow RT, Johnson MI, Lopes-Martins RÁB, Bjordal JM. Efficacy of low-level laser therapy in the management of neck pain: a systematic review and meta-analysis of randomised placebo or active-treatment controlled trials [Internet]. Lancet. 2009 ; 374( 9705): 1897-1908.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/s0140-6736(09)61522-1
    • Vancouver

      Chow RT, Johnson MI, Lopes-Martins RÁB, Bjordal JM. Efficacy of low-level laser therapy in the management of neck pain: a systematic review and meta-analysis of randomised placebo or active-treatment controlled trials [Internet]. Lancet. 2009 ; 374( 9705): 1897-1908.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/s0140-6736(09)61522-1
  • Source: Lancet. Unidade: FM

    Assunto: VIOLÊNCIA CONTRA A MULHER

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      D'OLIVEIRA, Ana Flávia Pires Lucas e DINIZ, Simone Grilo e SCHRAIBER, Lilia Blima. Violence against women in health-care institutions: an emerging problem. Lancet, v. 359, p. 1681-1685, 2002Tradução . . Disponível em: https://doi.org/10.1016/s0140-6736(02)08592-6. Acesso em: 08 nov. 2024.
    • APA

      D'Oliveira, A. F. P. L., Diniz, S. G., & Schraiber, L. B. (2002). Violence against women in health-care institutions: an emerging problem. Lancet, 359, 1681-1685. doi:10.1016/s0140-6736(02)08592-6
    • NLM

      D'Oliveira AFPL, Diniz SG, Schraiber LB. Violence against women in health-care institutions: an emerging problem [Internet]. Lancet. 2002 ; 359 1681-1685.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/s0140-6736(02)08592-6
    • Vancouver

      D'Oliveira AFPL, Diniz SG, Schraiber LB. Violence against women in health-care institutions: an emerging problem [Internet]. Lancet. 2002 ; 359 1681-1685.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/s0140-6736(02)08592-6
  • Source: Lancet. Unidade: FMRP

    Subjects: INFARTO DO MIOCÁRDIO (TRATAMENTO), ISQUEMIA MIOCÁRDICA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MARIN-NETO, José Antônio. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet, v. 358, n. 9282, p. 605-613, 2001Tradução . . Acesso em: 08 nov. 2024.
    • APA

      Marin-Neto, J. A. (2001). Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet, 358( 9282), 605-613.
    • NLM

      Marin-Neto JA. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet. 2001 ; 358( 9282): 605-613.[citado 2024 nov. 08 ]
    • Vancouver

      Marin-Neto JA. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet. 2001 ; 358( 9282): 605-613.[citado 2024 nov. 08 ]
  • Source: Lancet. Unidade: FMRP

    Subjects: FÁRMACOS SINTÉTICOS, MEDICAÇÃO ORAL, ISQUEMIA MIOCÁRDICA (TRATAMENTO)

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MEHTA, Shamir R. et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, v. 358, n. 9281, p. 527-533, 2001Tradução . . Disponível em: https://doi.org/10.1016/s0140-6736(01)05701-4. Acesso em: 08 nov. 2024.
    • APA

      Mehta, S. R., Yusuf, S., Peters, R. J. G., Bertrand, M. E., Lewis, B. S., Natarajan, M. K., et al. (2001). Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, 358( 9281), 527-533. doi:10.1016/s0140-6736(01)05701-4
    • NLM

      Mehta SR, Yusuf S, Peters RJG, Bertrand ME, Lewis BS, Natarajan MK, Malmberg K, Rupprecht H-J, Zhao F, Chrolavicius S, Copland I, Fox KAA, Marin-Neto JA. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study [Internet]. Lancet. 2001 ; 358( 9281): 527-533.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/s0140-6736(01)05701-4
    • Vancouver

      Mehta SR, Yusuf S, Peters RJG, Bertrand ME, Lewis BS, Natarajan MK, Malmberg K, Rupprecht H-J, Zhao F, Chrolavicius S, Copland I, Fox KAA, Marin-Neto JA. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study [Internet]. Lancet. 2001 ; 358( 9281): 527-533.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/s0140-6736(01)05701-4
  • Source: Lancet. Unidade: FMRP

    Subjects: CARDIOPATIAS, MEDICINA INTERNA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      WERF, Frans Van de e MARIN NETO, José Antonio. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet, v. 354, p. 716-722, 1999Tradução . . Disponível em: https://doi.org/10.1016/s0140-6736(99)07403-6. Acesso em: 08 nov. 2024.
    • APA

      Werf, F. V. de, & Marin Neto, J. A. (1999). Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet, 354, 716-722. doi:10.1016/s0140-6736(99)07403-6
    • NLM

      Werf FV de, Marin Neto JA. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial [Internet]. Lancet. 1999 ; 354 716-722.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/s0140-6736(99)07403-6
    • Vancouver

      Werf FV de, Marin Neto JA. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial [Internet]. Lancet. 1999 ; 354 716-722.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/s0140-6736(99)07403-6
  • Source: Lancet. Unidade: HU

    Assunto: NEONATOLOGIA

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ZULLINI, Maria Teresa e BONATI, Maurizio. Geographical bias of prognostic scoring systems?. Lancet, v. 342, n. 8879, p. 1115, 1993Tradução . . Disponível em: https://doi.org/10.1016/0140-6736(93)92098-e. Acesso em: 08 nov. 2024.
    • APA

      Zullini, M. T., & Bonati, M. (1993). Geographical bias of prognostic scoring systems? Lancet, 342( 8879), 1115. doi:10.1016/0140-6736(93)92098-e
    • NLM

      Zullini MT, Bonati M. Geographical bias of prognostic scoring systems? [Internet]. Lancet. 1993 ; 342( 8879): 1115.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/0140-6736(93)92098-e
    • Vancouver

      Zullini MT, Bonati M. Geographical bias of prognostic scoring systems? [Internet]. Lancet. 1993 ; 342( 8879): 1115.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/0140-6736(93)92098-e
  • Source: Lancet. Unidade: IB

    Assunto: CARIOTIPAGEM

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      OTTO, Paulo A et al. Risk of 45,X karyotype in offspring of turner's syndrome patients. [Letters to the editor]. Lancet. London: Instituto de Biociências, Universidade de São Paulo. . Acesso em: 08 nov. 2024. , 1977
    • APA

      Otto, P. A., Kasahara, S., Nunesmaia, H. G. da S., & Frota-Pessoa, O. (1977). Risk of 45,X karyotype in offspring of turner's syndrome patients. [Letters to the editor]. Lancet. London: Instituto de Biociências, Universidade de São Paulo.
    • NLM

      Otto PA, Kasahara S, Nunesmaia HG da S, Frota-Pessoa O. Risk of 45,X karyotype in offspring of turner's syndrome patients. [Letters to the editor]. Lancet. 1977 ; 2 257.[citado 2024 nov. 08 ]
    • Vancouver

      Otto PA, Kasahara S, Nunesmaia HG da S, Frota-Pessoa O. Risk of 45,X karyotype in offspring of turner's syndrome patients. [Letters to the editor]. Lancet. 1977 ; 2 257.[citado 2024 nov. 08 ]

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024